TrialClinical pharmacology and therapeutics2020

Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial.

Abhijeet Jakate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.